Universität zu Köln

Loibl, S., Reinisch, M., Denkert, C., Fasching, P. A., Seiler, S., Link, T., Hanusch, C., Bjelic-Radisic, V., Schneeweiss, A., Huober, J., Jackisch, C., Rhiem, K. E., Untch, M., Solbach, C., Blohmer, J-U., Buechele, T., Nekljudova, V. and Loi, S. (2022). A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC)-GeparPiPPa. Ann. Oncol., 33 (7). S. S627 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Loibl, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Reinisch, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Denkert, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Fasching, P. A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Seiler, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Link, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Hanusch, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Bjelic-Radisic, V. UNSPECIFIED UNSPECIFIED UNSPECIFIED Schneeweiss, A. UNSPECIFIED UNSPECIFIED UNSPECIFIED Huober, J. UNSPECIFIED UNSPECIFIED UNSPECIFIED Jackisch, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Rhiem, K. E. UNSPECIFIED UNSPECIFIED UNSPECIFIED Untch, M. UNSPECIFIED UNSPECIFIED UNSPECIFIED Solbach, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Blohmer, J-U. UNSPECIFIED UNSPECIFIED UNSPECIFIED Buechele, T. UNSPECIFIED UNSPECIFIED UNSPECIFIED Nekljudova, V. UNSPECIFIED UNSPECIFIED UNSPECIFIED Loi, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-695387
DOI:	10.1016/j.annonc.2022.07.235
Journal or Publication Title:	Ann. Oncol.
Volume:	33
Number:	7
Page Range:	S. S627 - 1
Date:	2022
Publisher:	ELSEVIER
Place of Publication:	AMSTERDAM
ISSN:	1569-8041
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language Oncology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/69538